NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This trial investigate add-on treatment with 3 g NAC vs. placebo in 20 weeks in patients
suffering from bipolar depression. The primary outcome is MADRS-score, and the secondary
outcomes are other psychometric evaluations oxidative stress biomarkers in urine.